DrugPatentWatch Database Preview
Watson Labs Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?
WATSON LABS has one thousand and thirty-five approved drugs.
There are twenty tentative approvals on WATSON LABS drugs.
Summary for Watson Labs
| US Patents: | 0 |
| Tradenames: | 400 |
| Ingredients: | 377 |
| NDAs: | 1035 |
Drugs and US Patents for Watson Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | PREDNISONE | prednisone | TABLET;ORAL | 085162-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Watson Labs Teva | LEVOFLOXACIN | levofloxacin | SOLUTION/DROPS;OPHTHALMIC | 076826-001 | Feb 10, 2011 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Watson Labs | PEMOLINE | pemoline | TABLET;ORAL | 075287-003 | Sep 18, 2000 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
